Susan L. Holbeck

The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity

Susan L. Holbeck, Richard F. Camalier, James A. Crowell et al. · Cancer Research · 2017 · 392 citations · Full text

Medicine, Oncology, Pharmacology +12

Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines

Susan L. Holbeck, Jerry M. Collins, James H. Doroshow · Molecular Cancer Therapeutics · 2010 · 315 citations · Full text

Medicine, Oncology, Pharmacology +13

The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology

Ogan D. Abaan, Eric C. Polley, Sean Davis et al. · Cancer Research · 2013 · 286 citations

Medicine, Cancer Biology, Oncology +15

A Role for <i>REV3</i> in Mutagenesis During Double-Strand Break Repair in <i>Saccharomyces cerevisiae</i>

Susan L. Holbeck, Jeffrey N. Strathern · Genetics · 1997 · 200 citations

Life Sciences, Biology, Genetics +15

Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.

Barbara S. Nepom, Jerry P. Palmer, S J Kim et al. · The Journal of Experimental Medicine · 1986 · 189 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17